Will inter partes review speed US generic drug entry?
Journal:
Nat Biotechnol
35(12):1139-1141
Publish Date:
2017-12-08
Author Profiles:
Will inter partes review speed US generic drug entry?
Speed, Safety, and Industry Funding - From PDUFA I to PDUFA VI.
Journal:
N Engl J Med
377(23):2278-2286
Publish Date:
2017-12-07
Author Profiles:
Speed, Safety, and Industry Funding - From PDUFA I to PDUFA VI.
Engineering Ethics and Self-Organizing Models of Human Development: Opportunities and Challenges.
Journal:
Cell Stem Cell
21(6):718-720
Publish Date:
2017-12-07
Author Profiles:
The FDA's Expedited Programs and Clinical Development Times for Novel Therapeutics, 2012-2016.
Journal:
JAMA
318(21):2137-2138
Publish Date:
2017-12-05
Author Profiles:
The FDA's Expedited Programs and Clinical Development Times for Novel Therapeutics, 2012-2016.
Cybersecurity Concerns and Medical Devices: Lessons From a Pacemaker Advisory.
Journal:
JAMA
318(21):2077-2078
Publish Date:
2017-12-05
Author Profiles:
Comprehensive Mapping of Pluripotent Stem Cell Metabolism Using Dynamic Genome-Scale Network Modeling.
Correlates of early pregnancy serum brain-derived neurotrophic factor in a Peruvian population.
Journal:
Arch Womens Ment Health
20(6):777-785
Publish Date:
2017-12-01
Author Profiles: